Degarelix is a gonadotropin-releasing hormone receptor antagonist used in the treatment of advanced prostate cancer. It works by decreasing testosterone levels, which helps slow the growth of cancer cells. Degarelix is typically administered by injection and may cause side effects such as injection site reactions and hot flashes. In summary, Degarelix is crucial for managing prostate cancer.
Degarelix blocks the action of gonadotropin-releasing hormone (GnRH), leading to reduced testosterone production and inhibition of prostate cancer cell growth.